DuPont de Nemours (DD) Stock Overview
Provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
DD Community Fair Values
Create NarrativeSee what 56 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
DuPont de Nemours, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$46.84 |
| 52 Week High | US$83.40 |
| 52 Week Low | US$33.34 |
| Beta | 1.08 |
| 1 Month Change | -7.32% |
| 3 Month Change | 4.32% |
| 1 Year Change | -31.56% |
| 3 Year Change | -32.81% |
| 5 Year Change | -39.78% |
| Change since IPO | 381.78% |
Recent News & Updates
Narrative Update • May 30
DD: Guidance Reaffirmation And Buybacks Will Support Future Upside Potential
Analysts have nudged their price target for DuPont de Nemours slightly higher to $64.00, citing updated assumptions for revenue growth, profit margins and future P/E that refine rather than overhaul their outlook on the stock. What's in the News Shareholders approved an amendment to the Certificate of Incorporation to allow a reverse stock split between 1-for-2 and 1-for-4, along with a corresponding reduction in authorized common shares at the May 21, 2026 AGM (Changes in Company Bylaws/Rules).Seeking Alpha • May 27
I See A Better DuPont, Not A Bargain
Summary DuPont de Nemours, Inc. is a leading science and materials company supplying specialized products to manufacturers, not direct consumers. DD recently sold its Aramids division, including Kevlar and Nomex, for $1.8 billion, streamlining its portfolio. AI and data center demand are driving significant growth in DD's microelectronics segment, making it a core business focus. After years of underperformance, DD shares have begun to outperform the S&P 500, supported by a reverse split and reaffirmed 2026 guidance. Read the full article on Seeking AlphaNarrative Update • May 07
DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside
Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.Recent updates
Narrative Update • May 30
DD: Guidance Reaffirmation And Buybacks Will Support Future Upside Potential
Analysts have nudged their price target for DuPont de Nemours slightly higher to $64.00, citing updated assumptions for revenue growth, profit margins and future P/E that refine rather than overhaul their outlook on the stock. What's in the News Shareholders approved an amendment to the Certificate of Incorporation to allow a reverse stock split between 1-for-2 and 1-for-4, along with a corresponding reduction in authorized common shares at the May 21, 2026 AGM (Changes in Company Bylaws/Rules).Seeking Alpha • May 27
I See A Better DuPont, Not A Bargain
Summary DuPont de Nemours, Inc. is a leading science and materials company supplying specialized products to manufacturers, not direct consumers. DD recently sold its Aramids division, including Kevlar and Nomex, for $1.8 billion, streamlining its portfolio. AI and data center demand are driving significant growth in DD's microelectronics segment, making it a core business focus. After years of underperformance, DD shares have begun to outperform the S&P 500, supported by a reverse split and reaffirmed 2026 guidance. Read the full article on Seeking AlphaNarrative Update • May 07
DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside
Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.Narrative Update • Apr 23
DD: PFAS Legal Overhang Will Set Up Future Water And Healthcare Upside
Analysts reaffirm a $64.00 price target on DuPont de Nemours, citing modest adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in their overall view of the shares. What's in the News DuPont plans to seek shareholder approval in May 2026 for a potential reverse stock split of its common stock at a ratio between 1 for 2 and 1 for 4, with the board retaining discretion on timing and whether to proceed.
Narrative Update • Apr 08
DD: Share Actions And Water Solutions Expansion Will Shape A Measured Outlook
Analysts have adjusted the price target for DuPont de Nemours from $44 to $50, reflecting updated assumptions around revenue growth, profit margins, a revised discount rate, and slightly lower future P/E expectations. What's in the News DuPont plans to seek shareholder approval to amend its certificate of incorporation to allow a reverse stock split of common shares at a ratio between 1-for-2 and 1-for-4, with the exact ratio and timing at the discretion of the board.Narrative Update • Mar 24
DD: PFAS Legal Overhang Will Set Up Future Product Expansion Upside
Analysts have raised their price target on DuPont de Nemours from about $55 to $64, citing updated assumptions for revenue growth, profit margins, and a lower discount rate that together support a reduced future P/E estimate. What's in the News The company plans to seek shareholder approval for a reverse stock split in a range of 1 for 2 to 1 for 4 at the May 21, 2026 annual meeting.
Narrative Update • Mar 09
DD: Water Technology Expansion And 2026 Guidance Will Support Future Upside
Analysts have kept their $56.13 price target for DuPont de Nemours unchanged, citing largely steady assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Together, these factors signal a consistent outlook on the stock's risk and return profile.Narrative Update • Feb 23
DD: New Guidance And Product Pipeline Will Support Future Upside
Analysts have raised their price target on DuPont de Nemours from about $49.19 to $56.13, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that they view as better reflecting the company’s potential risk and return profile. What's in the News Issued new earnings guidance for the first quarter of 2026, with expected net sales of $1,670 million.Analysis Article • Feb 17
There May Be Reason For Hope In DuPont de Nemours' (NYSE:DD) Disappointing Earnings
The market was pleased with the recent earnings report from DuPont de Nemours, Inc. ( NYSE:DD ), despite the profit...Narrative Update • Feb 09
DD: Legal PFAS Overhang Will Set Up Future Product Expansion Upside
Analysts have revised their price target for DuPont de Nemours from about US$113 to roughly US$55, reflecting updated views on fair value, a higher discount rate, softer revenue growth expectations, slightly lower profit margins, and a higher assumed future P/E multiple. What's in the News DuPont launched the FilmTec MXP RO-8038-FF reverse osmosis element for dairy processors, designed as a drop in option for mesh wrapped systems that targets around 5% higher active membrane area and up to 50% higher productivity compared with conventional mesh wrapped elements, while aiming to reduce wastewater and maintain existing plant setups (Product related announcement).Narrative Update • Jan 26
DD: Share Buybacks Will Drive Future Upside As New Plant Expands Capacity
Analysts have raised their price target for DuPont de Nemours from US$47.31 to US$49.19, citing updated assumptions around discount rates, revenue trends, profit margins and a revised future P/E outlook. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit related to alleged PFAS risks in firefighter turnout gear that names DuPont alongside other manufacturers, allowing claims under multiple legal theories, including RICO, to proceed for now (Lawsuits & Legal Issues).Narrative Update • Jan 12
DD: Share Returns And Qnity Separation Will Frame A Measured Forward Outlook
Analysts have maintained their price target for DuPont de Nemours at $44.00, with this reaffirmed view supported by updated assumptions of a smaller revenue decline, higher profit margins, and a lower future P/E multiple. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit alleging DuPont and other manufacturers concealed health risks linked to PFAS chemicals in firefighter turnout gear, allowing RICO and other claims to proceed for now (Lawsuits & Legal Issues).Narrative Update • Dec 27
DD: Share Buybacks Will Drive Future Upside As New China Plant Expands Capacity
Narrative Update on DuPont de Nemours Analysts have modestly raised their average price target on DuPont de Nemours by approximately $0.06, reflecting slightly improved views on the company’s discount rate and profit margin outlook, despite marginally weaker revenue growth expectations. What's in the News Begins construction of a new MOLYKOTE specialty lubricants plant in Zhangjiagang, China, expanding global capacity and targeting fast growing demand across transportation, industrial, energy, and electronics markets, with operations expected to start in early 2027 (Key Developments) The board authorizes a share repurchase program of up to $2 billion, indicating a focus on capital returns to shareholders (Key Developments) Issues updated 2025 guidance, trimming full year net sales expectations to $6.84 billion and guiding fourth quarter net sales of about $1.685 billion (Key Developments) Declares a quarterly dividend of $0.20 per share, payable December 15, 2025, and also approves a pro rata special dividend to spin off Qnity to existing shareholders on November 1, 2025 (Key Developments) Introduces new safety and industrial products, including Tyvek APX high breathability chemical protective garments and IntegraTec XTP 100 IG ultrafiltration modules, together with new comfort and mobility testing protocols for soft ballistic body armor (Key Developments) Valuation Changes Fair Value: risen slightly from $47.25 to about $47.31 per share, indicating a marginally higher intrinsic value estimate.Narrative Update • Dec 13
DD: Share Returns And Qnity Separation Will Shape A Balanced Outlook
Narrative Update Analysts have cut their average 12 month price target on DuPont de Nemours to approximately 44 dollars from about 62 dollars. This reflects reduced expectations for revenue growth and profit margins, along with a higher assumed valuation multiple and discount rate.Narrative Update • Nov 29
DD: Share Repurchase Plan Will Drive Upside as New Plant Breaks Ground
Analysts have revised their price target for DuPont de Nemours downward by $6.00 to $47.25, citing recent adjustments in growth and profitability expectations. What's in the News DuPont broke ground on a new MOLYKOTE specialty lubricants manufacturing plant in Zhangjiagang, China.Narrative Update • Nov 15
DD: Future Share Buybacks Will Unlock Value Amid Uncertainty
Analysts have revised their price target for DuPont de Nemours sharply downward from $93.69 to $53.25, citing updated financial forecasts and increased market uncertainty. What's in the News DuPont unveiled Tyvek APX, a new disposable chemical garment fabric designed for increased comfort and breathability without compromising protection.Analysis Article • Nov 09
DuPont de Nemours (NYSE:DD) Is Paying Out Less In Dividends Than Last Year
DuPont de Nemours, Inc. ( NYSE:DD ) is reducing its dividend from last year's comparable payment to $0.20 on the 15th...Narrative Update • Nov 01
DD: Qnity Separation And Water Solutions Will Drive Outperformance
Analysts have slightly reduced their price target for DuPont de Nemours from $93.81 to $93.69. This change reflects modest adjustments in growth forecasts and profitability expectations.Narrative Update • Oct 17
Electronics, Healthcare And Water Will Drive Future Success
Analysts have raised their price target for DuPont de Nemours from $92.67 to $93.81. They cite modest improvements in profit margin expectations and slightly adjusted growth assumptions as the reasons for this change.Narrative Update • Sep 24
Electronics, Healthcare And Water Will Drive Future Success
Despite a reduced revenue growth outlook, improved net profit margins have driven the consensus analyst price target for DuPont de Nemours up from $89.31 to $92.67. What's in the News DuPont is actively pursuing strategic bolt-on acquisitions, focusing on enhancing capabilities and targeting growth opportunities, while maintaining a balanced approach between buybacks and M&A.Narrative Update • Sep 04
Electronics, Healthcare And Water Will Drive Future Success
As DuPont de Nemours’ revenue growth and discount rate forecasts remained steady, analysts kept their price target unchanged at $89.31. What's in the News Analyst/Investor Day announced.Analysis Article • Jul 23
Is DuPont de Nemours, Inc. (NYSE:DD) Trading At A 47% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, DuPont de Nemours fair value estimate is US$146 DuPont de...Seeking Alpha • Apr 07
DuPont: Upgrading To Hold Amid China Risks
Summary DuPont shares have underperformed the broader market since my Sell recommendation was published. A new antitrust probe by the Chinese government is a negative but the stock's valuation reflects this risk. I believe it will be difficult for the company to meet consensus EPS estimates given the macroeconomic backdrop. I up upgrading the stock to Hold as a view the risk-reward more balanced for the stock now than was previously the case. Read the full article on Seeking AlphaShareholder Returns
| DD | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -1.7% | 0.9% | -2.4% |
| 1Y | -31.6% | 4.9% | 21.5% |
Return vs Industry: DD underperformed the US Chemicals industry which returned 2.5% over the past year.
Return vs Market: DD underperformed the US Market which returned 20.6% over the past year.
Price Volatility
| DD volatility | |
|---|---|
| DD Average Weekly Movement | 5.2% |
| Chemicals Industry Average Movement | 7.1% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: DD has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: DD's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 15,000 | Lori Koch | www.dupont.com |
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors.
DuPont de Nemours, Inc. Fundamentals Summary
| DD fundamental statistics | |
|---|---|
| Market cap | US$18.25b |
| Earnings (TTM) | US$132.00m |
| Revenue (TTM) | US$6.92b |
143.7x
P/E Ratio2.7x
P/S RatioIs DD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DD income statement (TTM) | |
|---|---|
| Revenue | US$6.92b |
| Cost of Revenue | US$4.50b |
| Gross Profit | US$2.42b |
| Other Expenses | US$2.29b |
| Earnings | US$132.00m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 35.01% |
| Net Profit Margin | 1.91% |
| Debt/Equity Ratio | 22.6% |
How did DD perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield384%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/11 04:44 |
| End of Day Share Price | 2026/06/11 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
DuPont de Nemours, Inc. is covered by 36 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Selesky | Argus Research Company |
| Patrick Duffy Fischer | Barclays |
| Michael Leithead | Barclays |